First clinical-morphological tendencies of the treatment ofpatients with myoma of womb with ulipristal acetate

• Hauptverfasser: A L Tikhomirov (Verfasst von), V V Kazenashev (Verfasst von), O V Zayratyants (Verfasst von), I B Manukhin (Verfasst von)
• Format: Buch
• Veröffentlicht: IP Berlin A.V., 2014-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The objective. To assess the effectiveness of the selective progesterone receptor modulator ulipristal (Esmya) in presurgicaltherapy of patients with uterine myoma.Patients and methods. The examination included 23 patients with uterine myoma aged 37 to 42 years, 13 patients with uterine myoma aged 2...